investorscraft@gmail.com

Intrinsic ValueN2OFF, Inc. (NITO)

Previous Close$1.26
Intrinsic Value
Upside potential
Previous Close
$1.26

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

N2OFF, Inc. operates in the agricultural technology sector, focusing on innovative solutions to reduce nitrous oxide (N2O) emissions, a potent greenhouse gas. The company's core revenue model is driven by licensing its proprietary technology and forming strategic partnerships with agricultural producers and food companies. Its flagship product, a bio-based seed treatment, aims to enhance crop yields while minimizing environmental impact, positioning N2OFF as a niche player in the sustainable agtech space. The company targets large-scale farming operations and collaborates with research institutions to validate its technology's efficacy. Despite its small scale, N2OFF differentiates itself through a science-backed approach to emissions reduction, addressing a critical need in climate-conscious agriculture. The agtech industry is highly competitive, but N2OFF's specialized focus on N2O mitigation provides a unique value proposition in a market increasingly driven by regulatory and sustainability pressures.

Revenue Profitability And Efficiency

N2OFF reported modest revenue of $210,000 for the period, reflecting its early-stage commercialization efforts. The company posted a net loss of $5.2 million, with an EPS of -$0.89, indicating significant investment in R&D and market penetration. Operating cash flow was negative at $3.4 million, underscoring the cash-intensive nature of its growth phase. Capital expenditures were negligible, suggesting a lean operational model focused on intellectual property rather than physical assets.

Earnings Power And Capital Efficiency

The company's negative earnings highlight its pre-revenue stage, with losses driven by high R&D and operational costs. Capital efficiency remains a challenge, as evidenced by the substantial cash burn relative to revenue. However, the lack of significant debt and minimal capital expenditures suggest a strategic focus on preserving liquidity while scaling its technology.

Balance Sheet And Financial Health

N2OFF maintains a relatively strong liquidity position with $2.2 million in cash and equivalents, providing a short-term runway. Total debt is minimal at $7,000, indicating low leverage. The absence of dividends aligns with its growth-focused strategy, prioritizing reinvestment over shareholder returns. The balance sheet reflects a typical early-stage biotech profile, with limited liabilities but reliance on future funding to sustain operations.

Growth Trends And Dividend Policy

Growth prospects hinge on the adoption of its emission-reducing technology, which is still in the commercialization phase. The company does not pay dividends, redirecting all resources toward scaling its product offerings and partnerships. Given its niche market, success will depend on regulatory tailwinds and broader agricultural sustainability trends.

Valuation And Market Expectations

Market expectations for N2OFF are speculative, given its early-stage status and limited revenue. Valuation likely incorporates significant growth potential tied to climate-focused agricultural innovations. Investors may view the company as a high-risk, high-reward play on the intersection of agtech and environmental sustainability.

Strategic Advantages And Outlook

N2OFF's strategic advantage lies in its specialized technology addressing a critical environmental challenge. The outlook depends on its ability to secure partnerships, validate its product at scale, and navigate regulatory landscapes. Success could position it as a leader in sustainable agriculture, though execution risks remain high given the capital-intensive nature of the industry.

Sources

Company filings, CIK: 0001789192

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount